Xin Ma

机构：Harbin Medical University, Third Affiliated Hospital of Harbin Medical University · ORCID：0009-0002-7131-4245

发表论文 77 篇 · 总被引 1112 次 · h-index 17

代表论文

• Brigatinib Versus Alectinib in ALK-Positive NSCLC After Disease Progression on Crizotinib: Results of Phase 3 ALTA-3 Trial (2023 · Journal of Thoracic Oncology · 被引 51)
• NAT10/ac4C/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction (2024 · Journal of Experimental & Clinical Cancer Research · 被引 47)
• Biomarkers of ageing of humans and non-human primates (2025 · Nature Reviews Molecular Cell Biology · 被引 32)
• Targeting gut S. aureofaciens Tü117 serves as a new potential therapeutic intervention for the prevention and treatment of hypertension (2025 · Cell Metabolism · 被引 24)
• PD‐L1 regulates tumor proliferation and T‐cell function in NF2‐associated meningiomas (2024 · CNS Neuroscience & Therapeutics · 被引 11)
• Microbial responses and changes in metabolic products in bovine uteri infected with Staphylococcus aureus (2024 · International Journal of Biological Macromolecules · 被引 9)